XML 150 R109.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation - Summary of Key Terms and Conditions of Share-Based Compensation Based on Performance Conditions (Parenthetical) (Details) - SOD 2020 SOC2020 SOUS2020
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Percentage Of Exercisable Instruments Relating To Development Of The Product Pipeline Of The Company Evaluation date 20 october 2024   20.00%
Percentage of exercisable instruments relating to the development of elafibranor in pbc and elative clinical 25.00% 50.00%
Percentage of exercisable instruments relating to the development of NTZ and the ACLF franchise 15.00% 15.00%
Percentage of exercisable instruments relating to the NIS4 diagnostic technology   15.00%
Percentage of exercisable instruments relating to development of the product pipeline of the company   25.00%
Percentage of exercisable instruments relating to NI4 diagnostics technology   25.00%